BMC Medicine

official impact factor 5.75

Open Access Highly Access Email this article to a friend

Enhancement drugs: are there limits to what we should enhance and why?

Morten Hesse

BMC Medicine 2010, 8:50 doi:10.1186/1741-7015-8-50

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.